我們已在上線！進一步了解

Avanos Medical

AVNS

市值 US$11.7億

已下市

AVNS已於2026年7月24日下市。

返回排名列表

關於： Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.

員工： 2,287

醫療保健醫療器材

新聞

正面

中性

負面

市場情緒 3個月

正面 0%

中性 100%

負面 0%

Sterlington Advises Avanos Medical Management Team on $1.27 Billion Acquisition

NEW YORK--(BUSINESS WIRE)--Sterlington advises Avanos Medical management team on $1.27 billion acquisition.

Sterlington Advises Avanos Medical Management Team on $1.27 Billion Acquisition

Avanos Medical, Inc. Stockholders Approve Acquisition by American Industrial Partners

ALPHARETTA, Ga., July 22, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos" or the "Company"), a leading medical technology company, today announced that its stockholders have voted to approve the pending acquisition of Avanos by affiliates of investment funds advised by American Industrial Partners ("AIP") at a special meeting of stockholders (the "Special Meeting") held earlier today.

Avanos Medical, Inc. Stockholders Approve Acquisition by American Industrial Partners

Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600

NEW YORK, July 20, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600

Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600

Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger

ALPHARETTA, Ga. and NEW YORK, July 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos") and American Industrial Partners ("AIP") jointly announced the receipt of all required regulatory approvals to complete the pending acquisition of Avanos by affiliates of investment funds advised by AIP (the "Merger").

Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger

Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners. Under the terms of the proposed transaction, shareholders of Avanos will receive $25.00 in cash for each share of Avanos that they own. KSF is seeking to determine whether this consideration and the process that led to i.

Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS

Zacks Investment Research

Reasons to Retain Avanos Medical Stock in Your Portfolio for Now

AVNS' SNS momentum, Nexus Medical integration and AIP deal support growth, but tariff costs, margin pressure and PM&R weakness remain headwinds.

Reasons to Retain Avanos Medical Stock in Your Portfolio for Now

Zacks Investment Research

Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?

Zacks Investment Research

New Strong Sell Stocks for May 15th

AVNS, BKR and CAG have been added to the Zacks Rank #5 (Strong Sell) List on May 15th, 2026.

New Strong Sell Stocks for May 15th

Zacks Investment Research

Deciphering Avanos Medical (AVNS) International Revenue Trends

Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Deciphering Avanos Medical (AVNS) International Revenue Trends

Zacks Investment Research

AVNS Gains After Posting Q1 Earnings Miss & Revenue Beat, Margins Down

Avanos Medical tops Q1 revenue estimates on strong SNS growth, but margin pressure and PM&R weakness weigh on earnings and profitability.

AVNS Gains After Posting Q1 Earnings Miss & Revenue Beat, Margins Down

查看新聞排名

價格圖表採用Lightweight Charts™實作